ProShare Advisors
EXAS

ProShare Advisors’s Exact Sciences EXAS Stock Holding History

ProShare Advisors’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-3,049
Closed -$310K – 1927
2025
Q4 		$310K Buy
+3,049
New +$245K ﹤0.01% 1441
2022
Q2 		– Sell
-3,969
Closed -$278K – 1905
2022
Q1 		$278K Sell
3,969
-358
-8% -$26.2K ﹤0.01% 1679
2021
Q4 		$337K Buy
4,327
+251
+6% +$22.2K ﹤0.01% 1716
2021
Q3 		$389K Sell
4,076
-2,127
-34% -$225K ﹤0.01% 1362
2021
Q2 		$771K Buy
6,203
+3,025
+95% +$361K ﹤0.01% 1206
2021
Q1 		$419K Buy
3,178
+319
+11% +$43.7K ﹤0.01% 1562
2020
Q4 		$379K Buy
2,859
+261
+10% +$31.6K ﹤0.01% 1443
2020
Q3 		$265K Buy
2,598
+301
+13% +$26K ﹤0.01% 1259
2020
Q2 		$200K Buy
+2,297
New +$184K ﹤0.01% 1463
2020
Q1 		– Sell
-3,344
Closed -$309K – 1304
2019
Q4 		$309K Buy
3,344
+297
+10% +$26.1K ﹤0.01% 1325
2019
Q3 		$275K Sell
3,047
-94
-3% -$10.7K ﹤0.01% 1273
2019
Q2 		$371K Sell
3,141
-1,908
-38% -$192K ﹤0.01% 1135
2019
Q1 		$437K Buy
5,049
+1,435
+40% +$122K ﹤0.01% 1068
2018
Q4 		$228K Sell
3,614
-720
-17% -$49.4K ﹤0.01% 1301
2018
Q3 		$342K Buy
+4,334
New +$283K ﹤0.01% 1284
2018
Q2 		– Sell
-18,110
Closed -$730K – 1795
2018
Q1 		$730K Sell
18,110
-2,583
-12% -$126K ﹤0.01% 948
2017
Q4 		$1.09M Buy
20,693
+9,770
+89% +$522K 0.01% 801
2017
Q3 		$515K Buy
10,923
+1,221
+13% +$49.1K ﹤0.01% 953
2017
Q2 		$343K Sell
9,702
-2,468
-20% -$76.2K ﹤0.01% 1102
2017
Q1 		$287K Sell
12,170
-4,811
-28% -$95.3K ﹤0.01% 1261
2016
Q4 		$227K Buy
16,981
+6,544
+63% +$106K ﹤0.01% 1530
2016
Q3 		$194K Sell
10,437
-1,406
-12% -$24.8K ﹤0.01% 1349
2016
Q2 		$145K Buy
11,843
+103
+0.9% +$776 ﹤0.01% 1480
2016
Q1 		$79K Sell
11,740
-2,223
-16% -$14.2K ﹤0.01% 1533
2015
Q4 		$129K Buy
+13,963
New +$130K ﹤0.01% 1612
2015
Q3 		– Sell
-11,220
Closed -$334K – 1482
2015
Q2 		$334K Sell
11,220
-5,895
-34% -$148K ﹤0.01% 1265
2015
Q1 		$377K Sell
17,115
-669
-4% -$17K ﹤0.01% 1328
2014
Q4 		$488K Sell
17,784
-15,121
-46% -$368K 0.01% 1208
2014
Q3 		$638K Sell
32,905
-7,452
-18% -$137K 0.01% 1261
2014
Q2 		$687K Sell
40,357
-30,936
-43% -$426K 0.01% 1378
2014
Q1 		$1.01M Buy
+71,293
New +$963K 0.01% 1303
2013
Q4 		– Sell
-44,483
Closed -$525K – 1503
2013
Q3 		$525K Buy
44,483
+3,036
+7% +$39K 0.01% 1427
2013
Q2 		$577K Buy
+41,447
New +$450K 0.01% 1218

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.46B AUM 22.77% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

ProShare Advisors's EXAS Position: Q1 2026 in Review

ProShare Advisors sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 3,049 shares — an estimated $310K sold.

ProShare Advisors first reported a position in EXAS in Q2 2013 and held it in 33 quarters. The position peaked at $1.09M in Q4 2017. 6 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • ProShare Advisors reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • ProShare Advisors sold 3,049 Exact Sciences shares in Q1 2026, an estimated $310K.
  • ProShare Advisors first reported a position in Exact Sciences in Q2 2013 and held it in 33 quarters.
  • ProShare Advisors's Exact Sciences position peaked at $1.09M in Q4 2017.
  • 6 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on ProShare Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.